BioNTech SE (FRA:22UA)
Germany · Delayed Price · Currency is EUR 73.75
-1.50 (-1.99%)
At close: Mar 27, 2026
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of €17.85 billion as of March 27, 2026. Its market cap has decreased by -17.11% in one year.
Market Cap
17.85B
Enterprise Value
4.12B
Revenue
2.87B
Ranking
n/a
PE Ratio
n/a
Stock Price
€73.75
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 2.72B to 17.85B, an increase of 555.97%. That is a compound annual growth rate of 33.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 17.85B | -8.46% |
| Dec 31, 2025 | 19.50B | -26.11% |
| Dec 31, 2024 | 26.39B | 16.25% |
| Dec 29, 2023 | 22.70B | -33.55% |
| Dec 30, 2022 | 34.16B | -37.61% |
| Dec 31, 2021 | 54.75B | 241.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 46.48B |
| Siemens Healthineers AG | 40.52B |
| Bayer Aktiengesellschaft | 37.60B |
| Fresenius SE & Co. KGaA | 24.82B |
| Sartorius Aktiengesellschaft | 13.29B |
| Fresenius Medical Care AG | 10.57B |
| Fielmann Group AG | 3.62B |
| Ottobock SE & Co. KGaA | 3.44B |